Bon Natural Life Limited is projected to decline to $1.25 by 2027, a -2% move from its current price of $1.28. BON is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.25 | $1.28 | $1.31 | +0.03% |
| May 30 | $1.23 | $1.28 | $1.33 | +0.07% |
| May 31 | $1.22 | $1.28 | $1.34 | +0.10% |
| Jun 1 | $1.22 | $1.28 | $1.35 | +0.14% |
| Jun 2 | $1.21 | $1.28 | $1.36 | +0.17% |
| Jun 3 | $1.20 | $1.28 | $1.37 | +0.21% |
| Jun 4 | $1.20 | $1.28 | $1.37 | +0.24% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.20 | $1.28 | $1.37 | +0.24% |
| Week 2 | $1.17 | $1.29 | $1.42 | +0.49% |
| Week 3 | $1.14 | $1.29 | $1.45 | +0.73% |
| Week 4 | $1.13 | $1.29 | $1.48 | +0.97% |
| Week 5 | $1.11 | $1.30 | $1.51 | +1.22% |
| Week 6 | $1.10 | $1.30 | $1.54 | +1.46% |
| Week 7 | $1.08 | $1.30 | $1.56 | +1.71% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and the Middle East. The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. Bon Natural Life Limited serves manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries.
The company has a strategic partnership with Tigerbone Group Limited. Bon Natural Life Limited was founded in 2006 and is headquartered in Xi'an, the People's Republic of China.
Bon Natural Life Limited, BON, is currently priced at $1.27 with a market capitalization of $12.92M, and it ranks 5081 by market cap. The stock trades with a 30-day price range of $1.07 to $1.51, reflecting modest volatility in recent weeks. The forecast horizon shows a path from neutral in the near term to stronger upside later, with 2030 averaging $1.29 and 2040 averaging $2.12, and a long-run peak forecast around $6.22 in 2050, suggesting meaningful upside potential if the forecast unfolds.
A major floor 14.3% below — a decisive break under it would weaken the trend.
The nearest floor, 8.0% below — buyers have tended to step in here.
The nearest ceiling, 5.5% above — a clean break opens room to run.
A major ceiling 33.6% above — clearing it would confirm fresh momentum.
Key BON support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BON market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.28 | Sell | $1.28 | Buy |
| MA 10 | $1.27 | Buy | $1.27 | Buy |
| MA 20 | $1.26 | Buy | $1.27 | Buy |
| MA 50 | $1.30 | Sell | $1.33 | Sell |
| MA 100 | $1.47 | Sell | $1.51 | Sell |
| MA 200 | $1.62 | Sell | $4.01 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.86 | Neutral |
| Stoch RSI (14) | 80.63 | Sell |
| CCI (20) | 44.31 | Neutral |
| Williams %R (14) | -20.00 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 6.67 | Buy |
| Bollinger %B (20,2) | 0.65 | Neutral |
| Stochastic %K (14) | 80.00 | Sell |
| TRIX (15) | -0.19 | Sell |
| Awesome (5,34) | 0.01 | Buy |
| Ultimate (7,14,28) | 45.93 | Neutral |
| Momentum (10) | 0.06 | Buy |
| Aroon Osc (25) | -44.00 | Sell |
| Hull MA (9) | 1.28 | Buy |
| ADX (14) | 15.22 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is NEUTRAL with RSI14 at 50. The near-term averages show the 50-day simple moving average at $1.31 and the 200-day simple moving average at $1.62. Support is at $1.18 and resistance at $1.35, providing a modest trading band near the current price.
The 30-day range spans from $1.07 to $1.51, and annualized volatility is 50%, indicating elevated but manageable volatility within the recent window.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.18 | $1.28 | $1.67 | 0% | Neutral | |
| $0.9969 | $1.25 | $1.66 | -2% | Neutral | |
| $0.9414 | $1.21 | $1.67 | -5% | Neutral | |
| $0.9564 | $1.26 | $1.78 | -2% | Neutral | |
| $0.9668 | $1.30 | $1.88 | +1% | Neutral | |
| $1.08 | $1.48 | $2.19 | +16% | Neutral | |
| $1.15 | $1.59 | $2.39 | +24% | Bullish | |
| $1.14 | $1.61 | $2.46 | +26% | Bullish | |
| $1.11 | $1.58 | $2.45 | +24% | Bullish | |
| $1.03 | $1.49 | $2.35 | +17% | Neutral | |
| $1.39 | $2.14 | $3.57 | +67% | Bullish | |
| $1.98 | $3.41 | $6.22 | +167% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.18 | $1.28 | $1.51 | +0.00% |
| June 2026 | $1.13 | $1.33 | $1.59 | +3.70% |
| July 2026 | $1.12 | $1.32 | $1.61 | -0.48% |
| August 2026 | $1.11 | $1.33 | $1.63 | +0.35% |
| September 2026 | $1.15 | $1.37 | $1.70 | +3.46% |
| October 2026 | $1.15 | $1.38 | $1.72 | +0.40% |
| November 2026 | $1.10 | $1.33 | $1.67 | -3.16% |
| December 2026 | $1.09 | $1.33 | $1.67 | -0.57% |
Click any year to see its month-by-month BON forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, BON is projected to trade between $1.18 and $1.67, averaging $1.28 — a potential gain of 0% from today's $1.28. Price action looks broadly range-bound.
Bon Natural Life Limited's 2027 outlook centres on $1.25, within a $0.9969 to $1.66 range. That is -2% versus the projected 2026 average. That marks a -2% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, BON could reach as high as $1.67, with a base case around $1.21 and support toward $0.9414 — roughly -5% from $1.28. Price action looks broadly range-bound.
Expect BON to range from $0.9564 to $1.78 through 2029. The $1.26 average target implies a -2% move from current prices. That is up +4% on the projected 2028 average. A consolidation phase looks the most probable path here.
The BON price prediction for 2030 points to an average of $1.30 (low $0.9668, high $1.88) — a potential gain of +1% on today's $1.28. Price action looks broadly range-bound.
In 2031, BON is projected to trade between $1.08 and $2.19, averaging $1.48 — a potential gain of +16% from today's $1.28. That is up +14% on the projected 2030 average. A consolidation phase looks the most probable path here.
Bon Natural Life Limited's 2032 outlook centres on $1.59, within a $1.15 to $2.39 range. That is up +7% on the projected 2031 average. That marks a +24% change versus current levels. Momentum favours further upside here.
By 2033, BON could reach as high as $2.46, with a base case around $1.61 and support toward $1.14 — roughly +26% from $1.28. Buyers look set to stay in control over this stretch.
Expect BON to range from $1.11 to $2.45 through 2034. The $1.58 average target implies a +24% move from current prices. That is -2% versus the projected 2033 average. Momentum favours further upside here.
The BON price prediction for 2035 points to an average of $1.49 (low $1.03, high $2.35) — a potential gain of +17% on today's $1.28. A consolidation phase looks the most probable path here.
In 2040, BON is projected to trade between $1.39 and $3.57, averaging $2.14 — a potential gain of +67% from today's $1.28. That is up +43% on the projected 2035 average. Momentum favours further upside here.
Bon Natural Life Limited's 2050 outlook centres on $3.41, within a $1.98 to $6.22 range. That is up +59% on the projected 2040 average. That marks a +167% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in BON today (≈ 781.372089 BON) could be worth
$2,666.52
+$1,666.52 (+167%) by 2050 · US Dollar
Based on the average projected BON price of $3.41 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BONwould be worth at today's price.
$1,000 invested in BON on May 27, 2025 (≈ 564.971758 BON) would be worth
$723.05
-$276.95 (-27.7%) today · 0.72× · US Dollar
Based on a BON entry price of $1.77 vs. today's $1.28.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.3 | $986.74 | -1.3% |
| 1 month ago | $1.28 | $995.95 | -0.4% |
| 3 months ago | $1.64 | $781.32 | -21.9% |
| 6 months ago | $1.85 | $691.78 | -30.8% |
| 1 year ago | $1.77 | $723.05 | -27.7% |
| All time (4.9y) ago | $1,800 | $0.71 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BON forecast.
Our base-case forecast reaches $2.60 around 2050.
Implied market cap at $2.60: $15.83M
In 2030 the average price is $1.29 with a 1.5% return, and the range for that year runs from $0.9596 to $1.87. The forecast turns more bullish through the early 2030s, with 2031 averaging $1.47 and returning 15.7%, 2032 averaging $1.59 with 25.5%, and 2033 averaging $1.59 with 25.3%, followed by 2034 at $1.56 with 22.8% ROI and 2035 at $1.49 with 17.5% ROI. The outlook then shifts toward stronger gains, with 2040 averaging $2.12 and delivering 67.2% ROI, and 2050 averaging $3.41 with 168.6% ROI.
The sentiment turns BULLISH in 2032 onward and remains so in 2040 and 2050, though the sequence includes neutral years earlier and some years with modest gains. Overall, the long-term view shows upside potential, tempered by years of lower or neutral returns in the nearer term.
Tap a question to reveal the answer.
2030 avg $1.29 with ROI 1.5% (min $0.9596, max $1.87).
The forecast shows a neutral to positive path, with Neutral sentiment in the near term and Bullish outlook by 2040 and 2050, including a 67.2% ROI in 2040 and 168.6% ROI in 2050.
Yes. The forecast for 2031-2034 shows max values at or above $2.00 (2031 max $2.17, 2032 max $2.40, 2033 max $2.43, 2034 max $2.42). Additionally, 2040 and 2050 projects include higher price levels beyond $2.00.
Current price is $1.27 and market capitalization is $12.92M.
The 30-day range is $1.07 to $1.51.
Bon Natural Life Limited Community Discussion
0Share your Bon Natural Life Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.